Premium
Lower suicide risk with long‐term lithium treatment in major affective illness:
a meta‐analysis
Author(s) -
Tondo Leonardo,
Hennen John,
Baldessarini Ross J.
Publication year - 2001
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1034/j.1600-0447.2001.00464.x
Subject(s) - lithium (medication) , discontinuation , meta analysis , medicine , psychiatry , poison control , emergency medicine
Objective: To compare suicide rates with vs. without long‐term lithium treatment in major affective disorders. Method: Broad searching yielded 22 studies providing suicide rates during lithium maintenance; 13 also provide rates without such treatment. Study quality was scored, between‐study variance tested, and suicide rates on vs. off lithium examined by meta‐analyses using random‐effects regression methods to model risk ratios. Results: Among 5647 patients (33 473 patient‐years of risk) in 22 studies, suicide was 82% less frequent during lithium‐treatment (0.159 vs. 0.875 deaths/100 patient‐years). The computed risk‐ratio in studies with rates on/off lithium was 8.85 (95% CI, 4.12–19.1; P <0.0001). Higher rates off‐lithium were not accounted for by treatment‐discontinuation. Conclusion: Suicide risk was consistently lower during long‐term treatment of major affective illnesses with lithium in all studies in the meta‐analysis, including the few involving treatment‐randomization.